WO1992010464A1 - 4,5-dihydroxy- and 4,5,8-trihydroxy- 9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethans having therapeutical activities - Google Patents
4,5-dihydroxy- and 4,5,8-trihydroxy- 9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethans having therapeutical activities Download PDFInfo
- Publication number
- WO1992010464A1 WO1992010464A1 PCT/EP1991/002290 EP9102290W WO9210464A1 WO 1992010464 A1 WO1992010464 A1 WO 1992010464A1 EP 9102290 W EP9102290 W EP 9102290W WO 9210464 A1 WO9210464 A1 WO 9210464A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compounds
- hydrogen
- formula
- dioxo
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/12—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/44—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/96—Esters of carbonic or haloformic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/24—Anthracenes; Hydrogenated anthracenes
Definitions
- the present invention relates to 2-anthracenecar- boxylic derivatives of general formula (I)
- X is hydrogen or a OCOR group, in which R is as defined below;
- Y is hydrogen, C,-C 20 alkyl; C,-C, g alkoxyethyl; C,-C,g alkylthioethyl;
- R is a straight, branched or cyclic C,-C 20 alkoxy, ary- loxy, benzyloxy, 2-phenylethoxy group; R 1R2N, wherein R 1 and R2, which can be the same or different, are se ⁇ lected from hydrogen; straight, branched or alicyclic C- ⁇ -C j - alkyl, phenyl, benzyl, 2-phenylethyl; and to the pharmaceutically acceptable salts thereof.
- Preferred compounds of the invention are those in which R is selected from: methoxy, ethoxy, propoxy, bu- toxy, benzyloxy, methylamino, ethylamino, propylamino, benzylamino; Y is hydrogen or C,-C 4 alkyl, ethoxyethyl or ethylthioethyl.
- salts with alkali or alkaline-earth me ⁇ tals such as sodium, potassium, calcium or magnesium salts
- organic bases such as etha- nolamine, diethanolamine, N,N-dialkylethanolamine, phenylethylamine, piperazine, morpholine, lysine and the like.
- Compounds having a 9,10-anthraquinone structure, such as diacetylrhein, are known to have antiarthritic activity (DE 2711493).
- Italian Patent application n. 21456 A/87 discloses rhein derivatives wherein the hydroxy groups are repla- ced by thio groups.
- rhein and 8-hy- droxyrhein carbonic esters and urethans, of formula (I) have a marked inhibitory activity against the en ⁇ zymes involved in articular- pathology.
- the compounds of the invention proved to have a surpri ⁇ sing effect on mammal collagenase and elastase activi ⁇ ties, thus being advantageous in the therapeutical tre ⁇ atment of arthritic conditions.
- Said activities are particularly important in the treatment of cartilage pathology as well as in that of collagenous tissues.
- R0C0C1 wherein R is as defined above.
- Compounds (II) wherein Y is an alkyl, alkoxyethyl or alkylthioethyl group can be prepared by means of conventional esterification methods of compounds (II) in which Y is hydrogen.
- Compounds (I) in which R is a NR 1R2 group are pre- pared by reacting a compound of formula (II) above with phosgene and subsequently with a compound of formula
- compounds (I) wherein R is NR 1R2 are prepared by reacting a compound of formula (II) with a compound of formula R 1R2NOCl, wherein R1 and R2 are as defined above.
- the compounds of the invention can be used as such or in form of pharmaceutically acceptable salts the ⁇ reof, in the preparation of medicaments, together with suitable conventional carriers.
- solid formulations are tablets, capsu ⁇ les, pills, or other forms of suitable bio-availabi- lity. Dosages can range from 5 to 500 mg per unit dose, the daily dose depending on the severity of the arthri ⁇ tic pathology and the patient's conditions, according to the physician judgement.
- EXAMPLE 8 Preparation of 4,5,8-tris(methylaminocarbonyloxy)-9,10 dihydro-9,10-dioxo-2-anthracenecarboxylic acid. 2.84 g of acid (I) are suspended in 70 ml of anhy drous tetrahydrofuran. The suspension is cooled to 0 P C it is added with 3.03 g (0.03 mole) of anhydrou triethylamine, then 16 ml of a solution of 20% phosgen in toluene are dropped therein.
- the formed chloride is dissolved in 200 ml of chloroform and the obtained so ⁇ lution is dropped into a mixture of 2 g (0.02 mole) of triethylamine and 2.2 g (0.02 mole) of 2-ethyl-thio- ethyl alcohol in 40 ml of chloroform, at a temperature of 0°-10 ⁇ C.
- the reaction is almost immediate at room temperature.
- solvent is evaporated off un ⁇ der vacuum, the residue is taken up into 40 ml of ben ⁇ zene and filtered.
- the filtrate is treated with 10% NH, and it is left to react for about 12 hours at room temperature.
- the solution is acidified to pH 5-6 with diluted HC1.
- Example 8 The procedure of Example 8 is followed, but using 2.7 g (8 mmoles) of the product of Example 15, 2.42 g (24 mmoles) of triethylamine and about 14 ml of a 20% C0C1 2 solution in toluene to prepare bis-chloroformate.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91920850A EP0561846B1 (en) | 1990-12-11 | 1991-12-03 | 4,5-dihydroxy- and 4,5,8-trihydroxy- 9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethans having therapeutical activities |
JP4500339A JPH06503078A (ja) | 1990-12-11 | 1991-12-03 | 治療活性を有する4,5−ジヒドロキシ−および4,5,8−トリヒドロキシ−9,10−ジヒドロ−9,10−ジオクソ−2−アントラセンカーボキシリック アシッドジカーボネートおよびウレタン |
US07/070,382 US5362750A (en) | 1990-12-11 | 1991-12-03 | 4,5-dihydroxy- and 4,5,8-trihydroxy- 9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethans having therapeutical activities |
AU90157/91A AU657290B2 (en) | 1990-12-11 | 1991-12-03 | 4,5-dihydroxy- and 4,5,8-trihydroxy- 9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethans having therapeutical activities |
DE69108408T DE69108408T2 (de) | 1990-12-11 | 1991-12-03 | 4,5-dihydroxy und 4,5,8-trihydroxy-9,10-dioxo-2-anthracencarbonsäure-dikohlensäureester und urethane mit therapeutischer wirkung. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT22343A/90 | 1990-12-11 | ||
IT02234390A IT1244886B (it) | 1990-12-11 | 1990-12-11 | Dicarbonati e uretani dell'acido 4,5-diidrossi- e 4,5,8-triidrossi- 9,10-diidro-9,10-diosso-2-antracencarbossilico ad azione terapeutica |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1992010464A1 true WO1992010464A1 (en) | 1992-06-25 |
Family
ID=11194956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1991/002290 WO1992010464A1 (en) | 1990-12-11 | 1991-12-03 | 4,5-dihydroxy- and 4,5,8-trihydroxy- 9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethans having therapeutical activities |
Country Status (13)
Country | Link |
---|---|
US (1) | US5362750A (pt) |
EP (1) | EP0561846B1 (pt) |
JP (1) | JPH06503078A (pt) |
AT (1) | ATE120180T1 (pt) |
AU (1) | AU657290B2 (pt) |
CA (1) | CA2098112A1 (pt) |
DE (1) | DE69108408T2 (pt) |
DK (1) | DK0561846T3 (pt) |
ES (1) | ES2069915T3 (pt) |
IT (1) | IT1244886B (pt) |
MX (1) | MX9102518A (pt) |
PT (1) | PT99737A (pt) |
WO (1) | WO1992010464A1 (pt) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5430067A (en) * | 1993-08-13 | 1995-07-04 | Eli Lilly And Company | Pharmaceutical compounds |
US5480873A (en) * | 1992-02-28 | 1996-01-02 | Lilly Industries Limited | Pharmaceutical compounds |
US5484935A (en) * | 1993-08-13 | 1996-01-16 | Lilly Industries Limited | Pharmaceutical compounds |
US5668172A (en) * | 1994-08-24 | 1997-09-16 | Lilly Industries Limited | Anthraquinone pharmaceutical compounds and uses therefor |
WO2002022119A1 (fr) * | 2000-09-15 | 2002-03-21 | Negma-Lerads | Utilisation d'une rhéine pour la préparation d'un médicament pour la prévention de la dégradation du cartilage articulaire |
KR100715076B1 (ko) | 2005-06-10 | 2007-05-04 | 대화제약 주식회사 | 디아세레인의 새로운 제조방법 |
US20080207758A1 (en) * | 2005-07-11 | 2008-08-28 | Xiaodong Cong | Rhein Conjugates, Preparation Method Thereof and Their Uses in Producing Medicines for Treating Diabetic Nephrosis, Intestinal Adhesion and Osteoarthritis |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6953788B1 (en) | 1996-09-19 | 2005-10-11 | Aventis Pharmaceuticals Inc. | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
US20050055024A1 (en) | 2003-09-08 | 2005-03-10 | James Anthony H. | Orthopaedic implant and screw assembly |
US9766269B2 (en) | 2012-12-29 | 2017-09-19 | Power Probe TEK, LLC | Conductive test probe |
JP6376340B2 (ja) * | 2014-06-26 | 2018-08-22 | 川崎化成工業株式会社 | 光ラジカル重合開始剤 |
CN109627169A (zh) * | 2017-12-05 | 2019-04-16 | 何黎琴 | No供体型大黄酸衍生物、其制备方法及医药用途 |
CN109053798B (zh) * | 2018-07-23 | 2020-11-17 | 遵义医科大学 | 一种大黄酸酯衍生物及其制备方法与应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2711493A1 (de) * | 1976-03-16 | 1977-10-06 | Charles Aubrey Friedmann | Substanzen zur behandlung von arthritis |
EP0243968A2 (en) * | 1986-05-02 | 1987-11-04 | PROTER S.p.A. | Diacetylrhein potassium salt and its therapeutical use in the treatment of arthritis |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH027302A (ja) * | 1988-06-27 | 1990-01-11 | Sumitomo Electric Ind Ltd | 有機導電性錯体 |
-
1990
- 1990-12-11 IT IT02234390A patent/IT1244886B/it active IP Right Grant
-
1991
- 1991-12-03 EP EP91920850A patent/EP0561846B1/en not_active Expired - Lifetime
- 1991-12-03 WO PCT/EP1991/002290 patent/WO1992010464A1/en active IP Right Grant
- 1991-12-03 JP JP4500339A patent/JPH06503078A/ja active Pending
- 1991-12-03 CA CA002098112A patent/CA2098112A1/en not_active Abandoned
- 1991-12-03 DE DE69108408T patent/DE69108408T2/de not_active Expired - Fee Related
- 1991-12-03 AT AT91920850T patent/ATE120180T1/de active
- 1991-12-03 ES ES91920850T patent/ES2069915T3/es not_active Expired - Lifetime
- 1991-12-03 DK DK91920850.4T patent/DK0561846T3/da active
- 1991-12-03 US US07/070,382 patent/US5362750A/en not_active Expired - Fee Related
- 1991-12-03 AU AU90157/91A patent/AU657290B2/en not_active Ceased
- 1991-12-10 PT PT99737A patent/PT99737A/pt not_active Application Discontinuation
- 1991-12-11 MX MX9102518A patent/MX9102518A/es not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2711493A1 (de) * | 1976-03-16 | 1977-10-06 | Charles Aubrey Friedmann | Substanzen zur behandlung von arthritis |
FR2508798A1 (fr) * | 1976-03-16 | 1983-01-07 | Proter Spa | Derives anthraquinoniques pour le traitement des arthrites |
EP0243968A2 (en) * | 1986-05-02 | 1987-11-04 | PROTER S.p.A. | Diacetylrhein potassium salt and its therapeutical use in the treatment of arthritis |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5480873A (en) * | 1992-02-28 | 1996-01-02 | Lilly Industries Limited | Pharmaceutical compounds |
US5430067A (en) * | 1993-08-13 | 1995-07-04 | Eli Lilly And Company | Pharmaceutical compounds |
US5484935A (en) * | 1993-08-13 | 1996-01-16 | Lilly Industries Limited | Pharmaceutical compounds |
US5668172A (en) * | 1994-08-24 | 1997-09-16 | Lilly Industries Limited | Anthraquinone pharmaceutical compounds and uses therefor |
US5792797A (en) * | 1994-08-24 | 1998-08-11 | Lilly Industries Limited | Pharmaceutical compounds |
WO2002022119A1 (fr) * | 2000-09-15 | 2002-03-21 | Negma-Lerads | Utilisation d'une rhéine pour la préparation d'un médicament pour la prévention de la dégradation du cartilage articulaire |
KR100715076B1 (ko) | 2005-06-10 | 2007-05-04 | 대화제약 주식회사 | 디아세레인의 새로운 제조방법 |
US20080207758A1 (en) * | 2005-07-11 | 2008-08-28 | Xiaodong Cong | Rhein Conjugates, Preparation Method Thereof and Their Uses in Producing Medicines for Treating Diabetic Nephrosis, Intestinal Adhesion and Osteoarthritis |
US9181172B2 (en) * | 2005-07-11 | 2015-11-10 | Xiaodong Cong | Rhein conjugates, preparation method thereof and their uses in producing medicines for treating diabetic nephrosis, intestinal adhesion and osteoarthritis |
Also Published As
Publication number | Publication date |
---|---|
DE69108408T2 (de) | 1995-07-27 |
AU9015791A (en) | 1992-07-08 |
IT9022343A1 (it) | 1992-06-11 |
US5362750A (en) | 1994-11-08 |
ES2069915T3 (es) | 1995-05-16 |
IT9022343A0 (it) | 1990-12-11 |
DK0561846T3 (da) | 1995-08-21 |
JPH06503078A (ja) | 1994-04-07 |
DE69108408D1 (de) | 1995-04-27 |
EP0561846B1 (en) | 1995-03-22 |
EP0561846A1 (en) | 1993-09-29 |
ATE120180T1 (de) | 1995-04-15 |
IT1244886B (it) | 1994-09-13 |
PT99737A (pt) | 1992-11-30 |
MX9102518A (es) | 1992-06-01 |
AU657290B2 (en) | 1995-03-09 |
CA2098112A1 (en) | 1992-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU657290B2 (en) | 4,5-dihydroxy- and 4,5,8-trihydroxy- 9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethans having therapeutical activities | |
CH651561A5 (fr) | Derives des nor-tropane et granatane et leur procede de preparation. | |
EP0274453A2 (fr) | Nouveaux composés à activité d'inhibiteurs de collagénase, procédé pour les préparer et compositions pharmaceutiques contenant ces composés | |
FR2606018A1 (fr) | Nouveaux a-aminoacides substitues, leur preparation et leur utilisation en therapeutique comme medicaments | |
KR20010088795A (ko) | EtO2C-CH2-(R)Cgl-Aze-Pab-OH의 결정질형태 | |
JPH0723359B2 (ja) | 二環式イミノ−α−カルボン酸エステルのジアステレオ異性体塩 | |
FR2532647A1 (fr) | Thioesters d'acide acetylsalicylique, procede pour les preparer et compositions pharmaceutiques qui en renferment | |
KR100224330B1 (ko) | 골관절 질환의 치료에 유용한 n-((4,5-디히드록시-및 4,5,8-트리히드록시-9,10-디히드로-9,10-디옥소-2-안트라센-일)카르보닐)아미노산 | |
AU1670092A (en) | Arylalkyl esters of 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid having therapeutical activity | |
GB2024814A (en) | Acyl (bicyclic aryl) - aminoalkanoic acids | |
JP3207017B2 (ja) | ベンジルコハク酸誘導体の製造方法およびその製造中間体 | |
KR100273603B1 (ko) | 치환된 벤조에이트 유도체 | |
US3985790A (en) | Phenoxyalkane carboxylic acid derivative | |
US2742460A (en) | Substituted piperidinopropane salt of penicillin | |
SE460969B (sv) | Apovincaminsyraderivat, foerfarande foer framstaellning daerav och farmaceutiska kompositioner innehaallande dessa derivat | |
US3264344A (en) | Arylamides of beta, beta-dimethyl-alpha, gamma-dihydroxy butyric acid and their alkanoyl ester derivatives | |
JP3058399B2 (ja) | [[4−置換アセチル−o−フェニレン]ジオキシ]ジ酢酸誘導体及びその製造方法 | |
JPWO2003062186A1 (ja) | (3s)−3−メトキシカルボニル−4−フェニル酪酸金属塩およびその使用方法 | |
KR900002874B1 (ko) | 아실우레이도 페니실린 유도체의 제조방법 | |
JPS62205043A (ja) | 9,10−ジヒドロ−フエナントレン誘導体およびその製法 | |
SU359811A1 (ru) | Способ получения галогенаминокарбокси производных | |
WO1994011390A1 (fr) | Nouveaux derives pseudodipeptidiques, leur preparation et leur utilisation comme antagonistes de la gastrine | |
JPH06293733A (ja) | 新規光学分割剤n−シンナモイルプロリン誘導体及びそのアルカリ塩 | |
JPS58164573A (ja) | 1−(4−クロロベンゾイル)−5−メトキシ−2−メチル−3−インド−ルアセトキシ酢酸類の製法 | |
HU186097B (en) | Process for the production of treo-3-amino-2-hydroxy-4-oxobutyric acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BB BG BR CA CS FI HU JP KP KR LK MG MN MW NO PL RO SD SU US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU MC ML MR NL SE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1991920850 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08070382 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2098112 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1991920850 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1991920850 Country of ref document: EP |